Dio Tree
PrivateLast Round
Seed
Dec 1, 2022
Total Funding Raised
$400,000
Company Overview
Dio Tree is a biotechnology company that develops a novel, first-in-class, small molecule for the treatment of ovarian cancer by inhibiting the DIO3 enzyme.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dio Tree Comps
Public and private peers based on sector, stage, and business model.
Dio Tree Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 1, 2022 |
Dio Tree Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed |
| NGT HealthCare II | Seed |
| Arieli Group | Seed |
| Hadasit - Hadassah Medical Center's Technology Transfer Company | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2022
$400K raised from Arieli Group, NGT HealthCare II, and others.
Dio Tree Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dio Tree's valuation, stock price, and market status.
